Connection
Mark Clements to Interleukin-23
This is a "connection" page, showing publications Mark Clements has written about Interleukin-23.
|
|
Connection Strength |
|
 |
|
 |
|
0.052 |
|
|
|
-
Forss A, Clements M, Myrelid P, Strid H, S?derman C, Wagner A, Andersson D, Hjelm F, Ol?n O, Halfvarson J, Ludvigsson JF. Ustekinumab Is Associated with Real-World Long-Term Effectiveness and Improved Health-Related Quality of Life in Crohn's Disease. Dig Dis Sci. 2023 01; 68(1):65-76.
Score: 0.052